In the latest market close, Pacific Biosciences of California (PACB) reached $1.44, with a -1.37% movement compared to the previous day. This move lagged the S&P 500's daily gain of 0.72%. Meanwhile, ...

Dr. Agarwal’s Health Care shares debuted at ₹402 on the NSE and ₹396.90 on the BSE, with an 8% drop shortly after. Analysts ...

S&P Global's SPGI short percent of float has fallen 10.0% since its last report. The company recently reported that it has ...

Gold Fields's GFI short percent of float has risen 36.84% since its last report. The company recently reported that it has ...

Cellebrite DI Ltd. offers unique digital investigative solutions to governmental agencies. Find out what makes CLBT stock a ...

So long as the mood on Wall Street remains so upbeat, the stock market will remain "an accident waiting to happen," according ...

Hedge funds bet against all sectors, but industrials, consumer discretionary, energy and communications equities bore the ...

Investors are now dealing with a new level of uncertainty, which is almost always bad for stocks. Uncertainty and fear are the two emotions that result in fast and aggressive selling patters as ...

Here are some key impacts to the markets from Trump’s tariffs and why investors are right to worry. After invoking emergency ...

Hedge funds last week jettisoned global stocks and added bets they would decline, said Goldman Sachs , just before U.S.

On Jan. 27, Nvidia ( NVDA -2.84%) fell 17%, erasing over $590 billion from its market cap. It marked the greatest single-day ...

Nvidia stock needs to jump 55% from current levels to hit $200. Consensus estimates are projecting a 50% increase in Nvidia's ...